SBFM Financials 07/16/2014 01:52:06 Sunshine Biop

SBFM Financials 07/16/2014 01:52:06
Sunshine Biopharma Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - 250
Gross Profit - - - (250)
Operating Expenses
Research and Development 137 2 143 -
Sales, General and Admin. 1,710 603 384 222
Non-Recurring Items 88 102 30 65
Other - - - -
Operating Income (1,936) (707) (556) (537)
Income From Continuing Operations
Add'l Income/Expense Items (549) - - -
Earnings Before Interest and Tax (2,485) (707) (556) (537)
Interest Expense 6 1 - -
Earnings Before Tax (2,491) (708) (556) (537)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,491) (708) (556) (537)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,491) (708) (556) (537)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,491) (708) (556) (537)